Major investment in Swedish production of advanced vaccines and biological drugs in Matfors

The Swedish investment company Flerie Invest has made a major investment to establish an innovation hub for advanced vaccines and biological drugs in Matfors in northern Sweden. The hub will provide Sweden with an infrastructure for process development and large-scale production in collaboration with innovative biotech companies.The establishment of the hub follows an acquisition of a subsidiary of the American company Charles River Laboratories Inc led by Flerie Invest. The new company will trade as NorthX Biologics. In addition to the $52m acquisition and further investment by Flerie